Latest Retinitis pigmentosa Stories
HUNTINGTON’S DISEASE, for the FIRST time in history was treated in March 2012 by Dr.’s Feinerman and Paino in our state of the art clinic in Lima, Peru.
Patients who have lost their sight due to some degenerative eye conditions may someday have their vision restored thanks to a new device developed by experts at the Stanford University School of Medicine.
Gene therapy strategies to prevent and treat inherited diseases of the retina that can cause blindness have progressed rapidly.
Two blind men have received sight for the first time in years due to new advances in medical science.
For the first time, scientists at the University of Wisconsin-Madison have made early retina structures containing proliferating neuroretinal progenitor cells using induced pluripotent stem (iPS) cells derived from human blood.
A newly developed, genetically modified pig may hold the keys to the development of improved treatments and possibly even a cure for retinitis pigmentosa (RP), the most common inherited retinal disease in the United States.
A new gene therapy method developed by University of Florida researchers has the potential to treat a common form of blindness that strikes both youngsters and adults.
Members of a University of Pennsylvania research team have shown that they can prevent, or even reverse, a blinding retinal disease, X-linked Retinitis Pigmentosa, or XLRP, in dogs.
Hitching a ride into the retina on nanoparticles called dendrimers offers a new way to treat age-related macular degeneration and retinitis pigmentosa.
- The abrogation of a law by a higher authority; annulment.